The ViBiA clinical study
Effectiveness of nutraceuticals in vitreoretinal inflammation
The ViBiA clinical study
Effectiveness of nutraceuticals in vitreoretinal inflammation
A multicenter, double‑blind clinical study designed to assess the ability of natural nutraceutical active ingredients with high antioxidant potential to reach the vitreoretinal district and exert an effective anti‑inflammatory action. The trial is led by Dr. Luca Ventre, Director of the Ophthalmology Unit at the Beauregard Hospital in Aosta, and involves six national university and hospital centers.
A multicenter, double‑blind clinical study designed to assess the ability of natural nutraceutical active ingredients with high antioxidant potential to reach the vitreoretinal district and exert an effective anti‑inflammatory action. The trial is led by Dr. Luca Ventre, Director of the Ophthalmology Unit at the Beauregard Hospital in Aosta, and involves six national university and hospital centers.
